Drug profile · INN
cediranib maleate
ZEMFIRZA
cediranib maleate (ZEMFIRZA) is an FDA-listed pharmaceutical active ingredient.
EMA: application withdrawn Antineoplastic and immunomodulating agents (L01) L01XE32
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — cediranib maleate
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
cediranib maleate (ZEMFIRZA) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN cediranib maleate
Brand ZEMFIRZA
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XE32
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cediranib maleate?
cediranib maleate (ZEMFIRZA) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for cediranib maleate?
ZEMFIRZA is a marketed brand name for cediranib maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.